Breaks Categories: Stock Spotlights

FridayDec 20, 2019 2:14 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Drug-Delivery Platform Continues Reaching New Milestones

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug-delivery platforms, recently announced further advances in its proprietary, oral, drug-delivery platform: DehydraTECH(TM). An article discussing the company reads, “Lexaria’s early pilot-stage human trials with tetrahydrocannabinol (THC) delivery show its newest formulation of DehydraTECH-enhanced edibles begin providing cannabinoid effectiveness in less than 10 minutes, which is about twice as fast as traditional DehydraTECH and four to six times faster than generic industry formulations, according to a company news release (http://cnw.fm/2owxO). . . . Lexaria has been developing DehydraTECH solutions as alternatives to smoked or vaped drug delivery over the course of…

Continue Reading

FridayDec 20, 2019 2:05 pm

CannabisNewsBreaks – HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) Attains Sizeable Revenue Gains During Q3

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF), a hemp-biomass processing entity, recently announced financial results for third quarter that showed a year-over-year (“YoY”) revenue increase of over 2.5 times. An article discussing the company reads, “HTC’s revenues grew from $1.3 million at the September close of the quarter in 2018 to $3.3 million at the quarter’s end this year, according to the report (http://cnw.fm/5bMiP). . . . The revenue gains continue to reflect growth in the company’s agri-infrastructure operation, but HTC anticipates significant new potential in the explosive growth of cannabinoid-related industries and is building hemp-biomass tolling contracts and extraction facilities…

Continue Reading

FridayDec 20, 2019 1:18 pm

CannabisNewsBreaks – LiveWire Ergogenics Inc. (LVVV) Achieves 935% YoY Revenue Increase in Q3 2019

LiveWire Ergogenics (OTC: LVVV) recently reported considerable net income increases during Q3 2019, including impressive year-over-year (“YoY”) revenue growth. An article discussing the results reads, “These figures, along with its emphasis on both producing and distributing world-class cannabis throughout the state of California, illuminate the company’s unique positioning in the ever-evolving cannabis industry. . . . In its report, the company noted a 935% boom in revenues, reaching $184,200 for Q3 2019 from $17,790 the same period the prior year (http://cnw.fm/SkM8a). For the 2019 quarter — the three months ended September 30 — LVVV showed a net income of $94,749 compared…

Continue Reading

FridayDec 13, 2019 3:31 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Focuses on Pioneering New Technologies

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) is a global innovator in drug-delivery platforms focused on its patented DehydraTECH-based, drug-delivery technology and formulation development. A recent article discussing the company reads, “Earlier this year, Lexaria moved into its new head office that includes a Health Canada-licensed research and development laboratory that is being used to conduct world-leading research into drug-delivery methods and improvements. In addition to accelerating research in the company’s DehydraTECH drug-delivery platform, Lexaria is also considering issuing a limited commercial release of DehydraTECH version 2.0, which has been shown to deliver 811% more CBD into animal blood than generic…

Continue Reading

FridayDec 13, 2019 2:47 pm

CannabisNewsBreaks – HTC Extraction Systems (TSX.V: HTC) Boosts Output Capacity through Kase Farma Inc. Acquisition

HTC Extraction Systems (TSX.V: HTC), a hemp-biomass processing entity, recently increased its capability and institutional knowledge through the acquisition of California-based Kase Farma Inc. An article discussing the company reads, “Kase Farma is active in the cultivation of hemp as well as the formulation and extraction of cannabinoids from hemp; the company is also licensed in the State of California to perform activities in those areas. At present, the company operates out of a 22,000-square-foot manufacturing facility and is currently implementing a scaled-up, high-throughput extraction facility that will utilize identity-preserved-grown (IPGrowTM), hemp-based cannabinoid biomass. IPGrowTM, according to the U.S. Department…

Continue Reading

FridayDec 13, 2019 2:41 pm

CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) Holds Potential to Supply Biosynthetically Derived Cannabinoids

Willow Biosciences (CSE: WLLW) (OTCQB: CANSF), an emerging biotechnology company focused on the biosynthetic production of cannabinoids, is well positioned to disrupt the cannabis industry supply chain by utilizing its ability to provide biosynthetically derived cannabinoids. A recent article discussing the company reads, “Willow ultimately intends to biosynthetically produce a variety of cannabinoids using biosynthesis, but its first target molecule will be CBD. The company has a fully integrated leadership team based out of Canada and the United States to handle all stages of the upstream cannabinoid development cycle. Additionally, by having two labs in Canada, where cannabis is federally…

Continue Reading

FridayDec 13, 2019 1:13 pm

CannabisNewsBreaks – LiveWire Ergogenics Inc. (LVVV) Establishing Central Operating Location at Flagship Facility in Paso Robles

LiveWire Ergogenics (OTC: LVVV) is continuing to advance research, cultivation and commercialization in the cannabis space at its flagship facility in Paso Robles, which is poised to become LiveWire’s central location for the company’s many operations. An article discussing the company reads, “Recently, LiveWire’s CEO Bill Hodson outlined the company’s creative business model in an exclusive interview with NetworkNewsAudio (‘NNA’). . . . Joined by NNW’s Stuart Smith, Bill Hodson, CEO of LiveWire, explained the reasoning behind LiveWire’s recent acquisition of the scenic 265-acre Estrella Ranch in Paso Robles, California (http://cnw.fm/NA5kG). In the interview Mr. Hodson compared the business model for…

Continue Reading

FridayDec 06, 2019 1:07 pm

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Secures Additional Funding to Advance Company Initiatives

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium, certified-organic cannabis, recently inked agreements for increased funding totaling up to $103 million. TGODF intends to utilize the capital to complete construction of various facilities and achieve national product distribution. An article discussing the company reads, “‘Our ability to raise capital, despite recent headwinds affecting the entire sector, is a clear show of confidence from our financial partners,’ TGOD CEO Brian Athaide stated in a news release. ‘It is reflective of the value of our significant assets, the trust investors are putting into TGOD’s strong corporate…

Continue Reading

FridayDec 06, 2019 12:50 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Names Senior Advisor to Outline Leadership Strategies

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator with technology that has demonstrated its ability to enhance the oral delivery of nicotine, recently appointed Gregg Smith, founder of a New York-based culture-tech, venture investment firm, as senior advisor to help define LXRP’s leadership strategies. An article discussing the company reads, “‘I am passionate about creating a smokeless future and recognize that the consumption methods of nicotine and cannabis will change,’ Smith stated in the news release (http://cnw.fm/KaCZ3). ‘Lexaria’s technology, DehydraTECH(TM), will completely disrupt and improve the consumption and delivery of oral nicotine, CBD and cannabis. Lexaria’s recognition of the…

Continue Reading

ThursdayDec 05, 2019 1:00 pm

CannabisNewsBreaks – LiveWire Ergogenics Inc. (LVVV) Set to Benefit Upon Senate Passing SAFE Banking Act Legislation

LiveWire Ergogenics (OTC: LVVV) is diligently watching the progress of the SAFE Banking Act, which would permit banks and credit unions to offer financial services to legal cannabis businesses once passed by the Senate. A recent article discussing the company reads, “In December 2018 the U.S. Farm Bill was passed, which de-scheduled hemp as a Schedule 1 drug, although the use, sale and possession of cannabis with over 0.3 percent THC remains illegal under Federal law. Despite that reclassification, most financial institutions continue to avoid providing services to businesses operating in the cannabis space. . . . The Secure and…

Continue Reading